Table of Content



List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Botulism - Overview
Botulism - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Botulism - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Botulism - Companies Involved in Therapeutics Development
CytoDel Inc
Hawaii Biotech Inc
Ology Bioservices Inc
Ossianix Inc
Botulism - Drug Profiles
botulism [serotype C] vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
botulism [serotypes A, B, E] (trivalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Ctyo-111 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclol Antibodies to Inhibit Botulinum Neurotoxin Type A for Botulism - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclol Antibody to Inhibit Botulinum Neurotoxin E for Botulism - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NTM-1632 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NTM-1633 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NTM-1634 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
OSX-400 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
OSX-400 Backups - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit Botulinum Neurotoxin Type A for Botulism - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit Botulinum Toxin for Botulism - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Botulism - Dormant Projects
Botulism - Discontinued Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures



Number of Products under Development for Botulism, H1 2019
Number of Products under Development by Companies, H1 2019
Number of Products under Development by Universities/Institutes, H1 2019
Number of Products by Targets, H1 2019
Number of Products by Stage and Targets, H1 2019
Number of Products by Mechanism of Actions, H1 2019
Number of Products by Stage and Mechanism of Actions, H1 2019
Number of Products by Routes of Administration, H1 2019
Number of Products by Stage and Routes of Administration, H1 2019
Number of Products by Molecule Types, H1 2019
Number of Products by Stage and Molecule Types, H1 2019


List of Tables



Number of Products under Development for Botulism, H1 2019
Number of Products under Development by Companies, H1 2019
Number of Products under Development by Universities/Institutes, H1 2019
Products under Development by Companies, H1 2019
Products under Development by Universities/Institutes, H1 2019
Number of Products by Stage and Target, H1 2019
Number of Products by Stage and Mechanism of Action, H1 2019
Number of Products by Stage and Route of Administration, H1 2019
Number of Products by Stage and Molecule Type, H1 2019
Botulism - Pipeline by CytoDel Inc, H1 2019
Botulism - Pipeline by Hawaii Biotech Inc, H1 2019
Botulism - Pipeline by Ology Bioservices Inc, H1 2019
Botulism - Pipeline by Ossianix Inc, H1 2019
Botulism - Dormant Projects, H1 2019
Botulism - Discontinued Products, H1 2019